MPLT
Price:
$18.58
Market Cap:
$14.67M
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's disease; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identif...[Read more]
Industry
Biotechnology
IPO Date
2025-10-24
Stock Exchange
NASDAQ
Ticker
MPLT
According to MapLight Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -81.38%. This represents a change of 219.57% compared to the average of -25.46% of the last 4 quarters.
The mean historical ROE of MapLight Therapeutics, Inc. over the last ten years is -96.44%. The current -81.38% ROE has changed -15.62% with respect to the historical average. Over the past ten years (40 quarters), MPLT's ROE was at its highest in in the June 2024 quarter at 0%. The ROE was at its lowest in in the March 2023 quarter at -57.41%.
Average
-96.44%
Median
-78.15%
Minimum
-143.82%
Maximum
-67.35%
Discovering the peaks and valleys of MapLight Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = -67.35%
Minimum Annual Increase = -45.66%
Minimum Annual ROE = -143.82%
| Year | ROE | Change |
|---|---|---|
| 2024 | -67.35% | -13.83% |
| 2023 | -78.15% | -45.66% |
The current ROE of MapLight Therapeutics, Inc. (MPLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-96.44%
5-year avg
-96.44%
10-year avg
-96.44%
MapLight Therapeutics, Inc.’s ROE is greater than ProMIS Neurosciences, Inc. (-336.93%), greater than Edesa Biotech, Inc. (-64.75%), greater than Ernexa Therapeutics Inc. (-1948.47%), greater than BiomX Inc. (-190.95%), greater than BioRestorative Therapies, Inc. (-233.25%), greater than Immuron Limited (-56.67%), greater than Dogwood Therapeutics, Inc. (-66.07%), greater than Lipocine Inc. (-30.64%), less than Traws Pharma, Inc. (77.88%), greater than OSR Holdings, Inc. (-21.88%),
| Company | ROE | Market cap |
|---|---|---|
| -336.93% | $15.70M | |
| -64.75% | $9.23M | |
| -1948.47% | $9.42M | |
| -190.95% | $10.76M | |
| -233.25% | $10.12M | |
| -56.67% | $5.19M | |
| -66.07% | $5.54M | |
| -30.64% | $49.91M | |
| 77.88% | $10.01M | |
| -21.88% | $16.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MapLight Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MapLight Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MapLight Therapeutics, Inc.'s ROE?
How is the ROE calculated for MapLight Therapeutics, Inc. (MPLT)?
What is the highest ROE for MapLight Therapeutics, Inc. (MPLT)?
What is the 3-year average ROE for MapLight Therapeutics, Inc. (MPLT)?
What is the 5-year average ROE for MapLight Therapeutics, Inc. (MPLT)?
How does the current ROE for MapLight Therapeutics, Inc. (MPLT) compare to its historical average?